Investor Alert

Alexion Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Mar 3, 2021, 7:40 p.m.





-4.19 -2.83%


Volume 129,592

Quotes are delayed by 20 min


Today's close

$ 150.37

$ 148.19


-2.18 -1.45%

Day low

Day high




52 week low

52 week high




Ellen V. Chiniara

Currently, Ellen V. Chiniara holds the position of Chief Legal Officer & Executive VP at Alexion Pharmaceuticals, Inc. and Secretary & Director at Abbott Rapid Dx North America LLC. She is also on the board of Greater Boston Chamber of Commerce.

In her past career Ms. Chiniara held the position of Partner at Wilmer Cutler Pickering Hale & Dorr LLP, Vice President & General Counsel for Women's Health USA, Inc., General Counsel of Internet Healthcare Group LLC, Assistant General Counsel at Value Health, Inc., Associate General Counsel-Neurology at EMD Serono, Inc. and Senior Vice President & General Counsel of Alere, Inc.

She received an undergraduate degree from Bryn Mawr College and a graduate degree from Stanford Law School.


Date Shares Transaction Value
12/16/2020 2,988   Derivative/Non-derivative trans. at $157.96 per share. 471,985
12/16/2020 16,925   Derivative/Non-derivative trans. at $157.96 per share. 2,673,473
12/16/2020 37,965   Award at $0 per share. 0
12/15/2020 56   Award at $95.53 per share. 5,349
03/02/2020 1,263   Derivative/Non-derivative trans. at $90.54 per share. 114,353
02/28/2020 10,200   Award at $0 per share. 0
12/15/2019 54   Award at $93.86 per share. 5,068
02/28/2019 8,250   Award at $0 per share. 0
02/28/2019 633   Derivative/Non-derivative trans. at $132.92 per share. 84,139
02/28/2018 8,344   Award at $0 per share. 0

Officers and Executives

Dr. Ludwig N. Hantson
Chief Executive Officer & Director
Dr. Aradhana Sarin
Chief Financial Officer & Executive Vice President
Mr. Brian M. Goff
Chief Commercial, Global Operations Officer & EVP
Mr. George Llado
Chief Information Officer & Senior Vice President
Dr. John J. Orloff
Executive VP, Head-Research & Development
Dr. Tanisha V. Cariño
Chief Corporate Affairs Officer & EVP
Dr. Gianluca Pirozzi
Head-Clinical Development, Hematology & Nephrology
Mr. Uzair Qadeer
Chief Diversity Officer
Ms. Becky Lillie
Chief Human Experience Officer
Ms. Tamar Thompson
Vice President-US Government Affairs & Policy
Ms. Indrani M. Franchini
Chief Compliance Officer & Executive VP
Ms. Rana Strellis
SVP-Global Culture & Social Responsibility
Mr. Daniel A. Bazarko
Chief Accounting Officer & Senior Vice President
Mr. Christopher J. Stevo
Head-Investor Relations1
Ms. Morgan Sanford
Chief of Staff
Ms. Ellen V. Chiniara
Secretary, Chief Legal Officer & Executive VP
Mr. David Richard Brennan
Dr. Andreas Rummelt
Independent Director
Mr. John T. Mollen
Independent Director
Mr. Christopher J. Coughlin
Independent Director
Dr. Paul A. Friedman
Independent Director
Dr. Francois Nader
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Ms. Judith A. Reinsdorf
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
Powered by StockTwits
Link to MarketWatch's Slice.